arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Nutex Health Inc.

NUTX
$161.74 ▼ -4.97 (-2.98%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
61 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Nutex Health Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.1B
Dividend Yield
Revenue Growth 2.2%
Op. Margin 37.5%
ROIC 18.0%
FCF / Share $10.63
Trailing P/E 24.1x
Price / Book 3.3x
FCF Yield 6.6%
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Aug 7, 2026.

61-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$216.49M
↑ +2.2%
Net Income Profit after all expenses
$46.81M
↑ +219.9%
Operating Margin Operating profit as % of sales
37.5%
↑ +84.2% 87th
FCF / Share Free cash flow per share
$10.63
↑ +15.1%
Long-Term Debt Long-term obligations
$24.26M
↓ -16.8%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
79
Returns
88
Financial Health
89
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 61 quarters